Correlation Between Dice Molecules and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dice Molecules and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dice Molecules and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dice Molecules Holdings and Akero Therapeutics, you can compare the effects of market volatilities on Dice Molecules and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dice Molecules with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dice Molecules and Akero Therapeutics.
Diversification Opportunities for Dice Molecules and Akero Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dice and Akero is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Dice Molecules Holdings and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Dice Molecules is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dice Molecules Holdings are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Dice Molecules i.e., Dice Molecules and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Dice Molecules and Akero Therapeutics
If you would invest 2,599 in Akero Therapeutics on August 31, 2024 and sell it today you would earn a total of 618.00 from holding Akero Therapeutics or generate 23.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.59% |
Values | Daily Returns |
Dice Molecules Holdings vs. Akero Therapeutics
Performance |
Timeline |
Dice Molecules Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akero Therapeutics |
Dice Molecules and Akero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dice Molecules and Akero Therapeutics
The main advantage of trading using opposite Dice Molecules and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dice Molecules position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.Dice Molecules vs. Nuvalent | Dice Molecules vs. Arcellx | Dice Molecules vs. Vaxcyte | Dice Molecules vs. Viridian Therapeutics |
Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |